Literature DB >> 10225338

Auditory hallucinations: phenomenology, neuropsychology and neuroimaging update.

A S David1.   

Abstract

Auditory verbal hallucinations (AVHs) are a cardinal feature of psychosis. Recent research is reviewed which has attempted to advance our knowledge of the mechanisms underlying this symptom. Phenomenological surveys have confirmed the importance of the content of such hallucinations and their meaning to the voice-hearer. Psychological and neuroimaging studies of inner speech and source monitoring have provided a neuropsychological framework for AVHs as well as some novel therapeutic strategies. There have also been successful attempts to 'capture' neural activity coincident with the experience of hallucinations using PET, SPECT and functional magnetic resonance imaging (MRI). This body of knowledge in combination with work on in-vivo receptor binding (dopamine and GABA) provides the beginnings of a cognitive and neurophysiological understanding of this complex and intriguing phenomenon.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225338     DOI: 10.1111/j.1600-0447.1999.tb05988.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  14 in total

1.  Brain correlates of subjective reality of physically and psychologically induced pain.

Authors:  Tuukka T Raij; Jussi Numminen; Sakari Närvänen; Jaana Hiltunen; Riitta Hari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 2.  A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations.

Authors:  Mark van der Gaag
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

3.  Activation of the caudal anterior cingulate cortex due to task-related interference in an auditory Stroop paradigm.

Authors:  Sven Haupt; Nikolai Axmacher; Michael X Cohen; Christian E Elger; Juergen Fell
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

4.  Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia.

Authors:  Judith M Ford; Vanessa A Palzes; Brian J Roach; Steven G Potkin; Theo G M van Erp; Jessica A Turner; Bryon A Mueller; Vincent D Calhoun; Jim Voyvodic; Aysenil Belger; Juan Bustillo; Jatin G Vaidya; Adrian Preda; Sarah C McEwen; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

5.  Network dynamics during the different stages of hallucinations in schizophrenia.

Authors:  Stéphanie Lefebvre; Morgane Demeulemeester; Arnaud Leroy; Christine Delmaire; Renaud Lopes; Delphine Pins; Pierre Thomas; Renaud Jardri
Journal:  Hum Brain Mapp       Date:  2016-03-26       Impact factor: 5.038

6.  Incautious reasoning as a pathogenetic factor for the development of psychotic symptoms in schizophrenia.

Authors:  Steffen Moritz; Todd S Woodward; Daniel Hausmann
Journal:  Schizophr Bull       Date:  2005-12-09       Impact factor: 9.306

7.  Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations.

Authors:  Andrea Mechelli; Paul Allen; Edson Amaro; Cynthia H Y Fu; Steven C R Williams; Michael J Brammer; Louise C Johns; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2007-11       Impact factor: 5.038

8.  Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study.

Authors:  Lahcen Ait Bentaleb; Mario Beauregard; Peter Liddle; Emmanuel Stip
Journal:  J Psychiatry Neurosci       Date:  2002-03       Impact factor: 6.186

Review 9.  The extended amygdala and the dopamine system: another piece of the dopamine puzzle.

Authors:  Julie L Fudge; Ana B Emiliano
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

10.  Reality of auditory verbal hallucinations.

Authors:  Tuukka T Raij; Minna Valkonen-Korhonen; Matti Holi; Sebastian Therman; Johannes Lehtonen; Riitta Hari
Journal:  Brain       Date:  2009-07-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.